SETTLEMENT AND TERMINATION AGREEMENTSettlement and Termination Agreement • November 25th, 2019 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 25th, 2019 Company IndustryThis SETTLEMENT AND TERMINATION AGREEMENT (this “Agreement”), dated November 25, 2019, is by and between Brickell Subsidiary, Inc., a Delaware corporation (formerly known as Brickell Biotech, Inc.) (“Brickell”), Brickell Biotech, Inc. a Delaware corporation (formerly known as Vical Incorporated) (“Parent”) and NovaQuest Co-Investment Fund X, L.P., a Delaware limited partnership (“NovaQuest”). Brickell, Parent and NovaQuest are together referred to as the “Parties” or individually as a “Party” in this Agreement. All capitalized terms not defined herein shall have the meanings ascribed to them in the Funding Agreement, as hereinafter defined.